- Report
- October 2025
- 190 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- January 2026
- 193 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 187 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 182 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- November 2025
- 184 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 190 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- July 2025
Global
From €4288EUR$4,900USD£3,728GBP
- Report
- January 2026
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- December 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- September 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- September 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- September 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- September 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- September 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- July 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- February 2026
- 377 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 383 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 468 Pages
Global
From €5120EUR$5,850USD£4,451GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more